X~Reta/GLP3(GLP1, GIP, & Glucagon) - appetite, metabolism, T2 diabetes.
Item #002
$89.99
Out of stock
Primarily being researched for weight loss and the treatment of type 2 diabetes. It works by activating multiple hormone receptors—GLP1, GIP, and Glucagon—to help regulate hunger, metabolism, and blood sugar levels. Unlike GLP1–only drugs, which can sometimes lead to muscle loss during rapid weight loss due to reduced appetite and calorie intake, Retatrutide may have a lower risk of muscle loss because of its unique multi-receptor action—especially its activation of GIP and GLP3 receptors.The addition of GLP3 activity may offer enhanced metabolic and anti-inflammatory benefits beyond traditional GLP1 therapies. Retatrutide is also being studied for its potential in treating obesity-related conditions such as fatty liver disease, obstructive sleep apnea, and knee osteoarthritis.
(Research Use Only)
Storage: 36°F to 46°F / 2°C to 8°C
DISCLAIMER: This product is intended for laboratory research purposes only. It is not intended for clinical or vet use. The purchaser assumes all responsibility for the use of this product in accordance with applicable laws and regulations.
